Fig. 10From: Analyzing molecular typing and clinical application of immunogenic cell death-related genes in hepatocellular carcinoma Drug prediction depends on ICDRM. A The relationship between PD-1 and CTLA-4 responsiveness differences between risk-low and risk-high subpopulations in TCGA. B Drugs predicted by the cMAP database, setting median tau score > -80. C Venn diagram for the drugs predicted by the R package “pRRophetic” and the cMAP database. D Using the PubChem website to predict the 3D structure of these intersection drugsBack to article page